Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial.
Perricone C, Scarsi M, Brucato A, Pisano P, Pigatto E, Becattini C, Cingolani A, Tiso F, Prota R, Tomasoni LR, Cutolo M, Tardella M, Rozza D, Zerbino C, Andreoni M, Poletti V, Bartoloni E, Gerli R; COLVID-19 study group, under the auspices of the Italian Society of Rheumatology (SIR), the Italian Society of Infectious and Tropical Diseases (SIMIT) and the Italian Thoracic Society (ITS-AIPO). Perricone C, et al. Among authors: becattini c. Eur J Intern Med. 2023 Jan;107:30-36. doi: 10.1016/j.ejim.2022.10.016. Epub 2022 Oct 31. Eur J Intern Med. 2023. PMID: 36396522 Free PMC article. Clinical Trial.
A platelet lipidomics signature in patients with COVID-19.
Goracci L, Petito E, Di Veroli A, Falcinelli E, Bencivenga C, Giglio E, Becattini C, De Robertis E, Vaudo G, Gresele P. Goracci L, et al. Among authors: becattini c. Platelets. 2023 Dec;34(1):2200847. doi: 10.1080/09537104.2023.2200847. Platelets. 2023. PMID: 37114418 Free article.
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators. Barco S, et al. Among authors: becattini c. Eur Heart J. 2020 Jan 21;41(4):509-518. doi: 10.1093/eurheartj/ehz367. Eur Heart J. 2020. PMID: 31120118 Clinical Trial.
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models.
Becattini C, Vedovati MC, Colombo S, Vanni S, Abrignani MG, Scardovi AB, Marrazzo A, Borselli M, Barchetti M, Fabbri A, Dentali F, Maggioni AP, Agnelli G, Gulizia MM; COPE Investigators(∗). Becattini C, et al. J Thromb Haemost. 2024 May 27:S1538-7836(24)00302-7. doi: 10.1016/j.jtha.2024.04.025. Online ahead of print. J Thromb Haemost. 2024. PMID: 38810699 Free article.
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study.
Cancelloni V, Buratti M, Tsivgoulis G, Furie KL, Tadi P, Caso V, Becattini C, Agnelli G, Zedde M, Abdul-Rahim AH, Alberti A, Venti M, de Magistris IL, Acciarresi M, D'Amore C, Mosconi MG, Cimini LA, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Bandini F, Marcheselli S, Pezzini A, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Sagris D, Adamou A, Vadikolias K, Palaiodimou L, Chondrogianni M, Mumoli N, Galati F, Sacco S, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Mancuso M, Orlandi G, Pascarella R, Tassinari T, Rueckert C, Baldi A, Toni D, Lettieri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Halvatsiotis P, Monaco S, Baronello MM, Csiba L, Szabò L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Kepplinger J, Deleu D, Gourbali V, Yaghi S, Paciaroni M; RAF, R. A. F.-NOACs Investigators. Cancelloni V, et al. Among authors: becattini c. Neurol Sci. 2024 May 22. doi: 10.1007/s10072-024-07555-z. Online ahead of print. Neurol Sci. 2024. PMID: 38775860
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, Bereczki D, Toni D, Seiffge DJ, Tanne D, Sandset EC, Tsivgoulis G, Christensen H, Beyer-Westendorf J, Coutinho JM, Crowther M, Verhamme P, Amarenco P, Roine RO, Mikulik R, Lemmens R, Veltkamp R, Middeldorp S, Robinson TG, Milling TJ Jr, Tedim-Cruz V, Lang W, Himmelmann A, Ladenvall P, Knutsson M, Ekholm E, Law A, Taylor A, Karyakina T, Xu L, Tsiplova K, Poli S, Kallmünzer B, Gumbinger C, Shoamanesh A; ANNEXA-I Investigators. Connolly SJ, et al. N Engl J Med. 2024 May 16;390(19):1745-1755. doi: 10.1056/NEJMoa2313040. N Engl J Med. 2024. PMID: 38749032 Clinical Trial.
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
Linder M, Ekbom A, Brobert G, Vogtländer K, Balabanova Y, Becattini C, Carrier M, Cohen AT, Coleman CI, Khorana AA, Lee AYY, Psaroudakis G, Abdelgawwad K, Rivera M, Schaefer B, Giunta DH. Linder M, et al. Among authors: becattini c. J Thromb Thrombolysis. 2024 May 12. doi: 10.1007/s11239-024-02992-1. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 38735015
258 results